Suppr超能文献

经口输出道缩小术治疗胃旁路术后体重反弹:长期随访。

Transoral outlet reduction for weight regain after gastric bypass: long-term follow-up.

机构信息

Developmental Endoscopy Lab, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts, USA.

出版信息

Gastrointest Endosc. 2016 Apr;83(4):776-9. doi: 10.1016/j.gie.2015.08.039. Epub 2015 Sep 5.

Abstract

BACKGROUND AND AIMS

Dilated gastrojejunal anastomosis aperture is associated with weight regain after Roux-en-Y gastric bypass (RYGB). Transoral outlet reduction (TORe) has proved safe and effective for the treatment of weight regain. The objective of this study was to determine the long-term weight trend and number needed to treat for TORe.

METHODS

This prospective series included consecutive post-RYGB patients with weight regain and a gastrojejunal anastomosis aperture greater than 15 mm. TORe was performed with a full-thickness endoscopic suturing device.

RESULTS

A total of 150 patients who had regained 49.9% ± 3.6% of the weight lost after gastric bypass (4.1 ± 0.3 kg/y after nadir) before TORe. At TORe, body mass index was 40.2 ± 0.8 kg/m(2) and weight was 110.7 ± 2.2 kg. At 1 year, weight loss was 10.5 ± 1.2 kg or 24.9 ± 2.6% excess weight loss (EWL); at 2 years, weight loss was 9.0 ± 1.7 kg or 20.0% ± 6.4% EWL; at 3 years, weight loss was 9.5 ± 2.1 kg or 19.2% ± 4.6% EWL. The number needed to treat for arrest of weight regain was 1.0 at 6 months, 1.1 at 1 year, and 1.2 at 2 and 3 years. The number needed to treat to maintain weight loss of ≥5 kg from TORe was 1.2 at 6 months, 1.5 at 1 year, 1.9 at 2 years, and 2.0 at 3 years.

CONCLUSION

TORe safely and effectively arrested weight regain and provided durable weight loss with a low number needed to treat. Patients with weight regain after RYGB should be evaluated for dilation of the gastrojejunal anastomosis, as TORe can be part of a multidisciplinary strategy to address post-RYGB weight regain.

摘要

背景与目的

Roux-en-Y 胃旁路术(RYGB)后胃空肠吻合口扩张与体重复增相关。经口输出道缩小术(TORe)已被证明对治疗体重复增安全有效。本研究旨在明确 TORe 的长期体重变化趋势和治疗所需人数。

方法

本前瞻性系列研究纳入了 RYGB 后体重复增且胃空肠吻合口大于 15mm 的连续患者。采用全层内镜缝合装置行 TORe。

结果

共纳入 150 例患者,这些患者在 TORe 前已复增 49.9%±3.6%的减重(最低体重后每年增加 4.1±0.3kg)。TORe 时,BMI 为 40.2±0.8kg/m2,体重为 110.7±2.2kg。1 年时体重减轻 10.5±1.2kg 或 24.9±2.6%的过量体重减轻(EWL);2 年时体重减轻 9.0±1.7kg 或 20.0%±6.4%EWL;3 年时体重减轻 9.5±2.1kg 或 19.2%±4.6%EWL。体重复增停止的治疗所需人数为 6 个月时 1.0,1 年时 1.1,2 年和 3 年时 1.2。TORe 后维持体重减轻≥5kg 的治疗所需人数为 6 个月时 1.2,1 年时 1.5,2 年时 1.9,3 年时 2.0。

结论

TORe 安全有效地阻止了体重复增,并提供了持久的减重效果,所需治疗人数较少。RYGB 后体重复增的患者应评估胃空肠吻合口扩张情况,因为 TORe 可以作为解决 RYGB 后体重复增的多学科策略的一部分。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验